In humans, carriers of a frameshift deletion of exon 9 in the LIPE gene, encoding for HSL, were characterized by metabolic dysfunction, including dyslipidemia, hepatic steatosis, systemic insulin resistance, and diabetes [22]. The gene discussed is LIPE; the disease is fatty liver disease.